miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects

Experimental and Therapeutic Medicine

Volumn 3, Issue 2, 2012, Pages 324-330

  Wang, Pingyu ^a   Xie, Shuyang ^b   Cui, Aidong ^c   Zhang, Yanxiang ^b   Jiang, Baofa ^a  

^a SHANDONG UNIVERSITY   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Hsa miR 196a2; Meta analysis; Polymorphism

Indexed keywords

MICRORNA; MICRORNA 196A2; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; HUMAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855393446     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.399     Document Type: Article

References (42)

1. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin encodes small RNAs with antisense complementarity to lin. Cell 75: 843-854, 1993.
2. Lau NC, Lim LP, Weinstein EG and Bartel DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862, 2001.
3. Macfarlane LA and Murphy PR: MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11: 537-561, 2010.
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Liu W, Mao SY and Zhu WY: Impact of tiny miRNAs on cancers. World J Gastroenterol 13: 497-502, 2007.
6. Davis CD and Ross SA: Evidence for dietary regulation of microRNA expression in cancer cells. Nutr Rev 66: 477-482, 2008.
7. Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG and Zhang L: The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125: 571-574, 2011.
8. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A and Tuschl T: New microRNAs from mouse and human. RNA 9: 175-179, 2003.
9. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y and Shen H: Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608, 2008.
10. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB and Wu X: Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 68: 2530-2537, 2008.
11. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, McClean MD, Marsit CJ and Kelsey KT: Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 16: 3713-3720, 2010.
12. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA and Wu X: Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1: 460-469, 2008.
13. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T and Wu X: Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14: 7956-7962, 2008.
14. George GP, Gangwar R, Mandal RK, Sankhwar SN and Mittal RD: Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep 38: 1609-1615, 2011.
15. Mittal RD, Gangwar R, George GP, Mittal T and Kapoor R: Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol 30: 401-406, 2011.
16. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X and Shen H: Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30: 79-84, 2009.
17. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69: 5970-5977, 2009.
18. Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y and Shen H: A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 18: 1183-1187, 2009.
19. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H and Cheng Q: Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55: 2288-2293, 2010.
20. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B and Peterlongo P: Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 31: E1052-E1057, 2010.
21. Dou T, Wu Q, Chen X, Ribas J, Ni X, Tang C, Huang F, Zhou L and Lu D: A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 136: 1853-1859, 2010.
22. Kim MJ, Yoo SS, Choi YY and Park JY: A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 69: 127-129, 2010.
23. Li XD, Li ZG, Song XX and Liu CF: A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42: 669-673, 2010.
24. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM and Wei Q: Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760, 2010.
25. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T and Hirata I: Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese Population. Helicobacter 15: 524-531, 2010.
26. Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang H and Gao CF: Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71: 621-626, 2010.
27. Srivastava K, Srivastava A and Mittal B: Common genetic variants in premicroRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55: 495-499, 2010.
28. Wang K, Guo H, Hu H, Xiong G, Guan X, Li J, Xu X, Yang K and Bai Y: A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers 15: 614-618, 2010.
29. Chen H, Sun LY, Chen LL, Zheng HQ and Zhang QF: A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J: Jan 17, 2011 (Epub ahead of print). doi: 10.1111/j.1445-5994 2011.02434.x.
30. Hong YS, Kang HJ, Kwak JY, Park BL, You CH, Kim YM and Kim H: Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health 44: 125-230, 2011.
31. Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie GZ, Sun AM and Liu Y: A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res 42: 144-148, 2011.
32. Zhou B, Wang K, Wang Y, Xi M, Zhang Z, Song Y and Zhang L: Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog 50: 499-505, 2011.
33. Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB and Shen HB: Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 45: 239-243, 2011 (In Chinese).
34. Akkiz H, Bayram S, Bekar A, Akgöllü E and Ulger Y: A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 18: e399-e407, 2011.
35. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S and Weinberg C: Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156: 300-310, 2002.
36. Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003.
37. Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101, 1994.
38. Egger M, Davey SG, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
39. Ryan BM, Robles AI and Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402, 2010.
40. Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A and Albarracin CT: MicroRNA-196a targets annexin A1: a microRNAmediated mechanism of annexin A1 downregulation in cancers. Oncogene 27: 6667-6678, 2008.
41. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR and Goodglick L: Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 37: 1583-1591, 2006.
42. Kim S and Misra A: SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng 9: 289-320, 2007.